nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—kidney cancer	0.268	0.5	CiPCiCtD
Nelarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—kidney cancer	0.268	0.5	CiPCiCtD
Nelarabine—POLA1—Gemcitabine—kidney cancer	0.109	0.619	CbGbCtD
Nelarabine—DCK—Gemcitabine—kidney cancer	0.067	0.381	CbGbCtD
Nelarabine—Cytarabine—Gemcitabine—kidney cancer	0.0595	0.35	CrCrCtD
Nelarabine—Azacitidine—Gemcitabine—kidney cancer	0.0565	0.333	CrCrCtD
Nelarabine—Decitabine—Gemcitabine—kidney cancer	0.0539	0.317	CrCrCtD
Nelarabine—DGUOK—Purine salvage—APRT—kidney cancer	0.00533	0.152	CbGpPWpGaD
Nelarabine—DGUOK—Purine metabolism—PPAT—kidney cancer	0.00272	0.0777	CbGpPWpGaD
Nelarabine—DGUOK—Purine metabolism—APRT—kidney cancer	0.00253	0.0722	CbGpPWpGaD
Nelarabine—ADA—Purine salvage—APRT—kidney cancer	0.00177	0.0505	CbGpPWpGaD
Nelarabine—DCK—Purine salvage—APRT—kidney cancer	0.00163	0.0466	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—PPAT—kidney cancer	0.00137	0.039	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—APRT—kidney cancer	0.00127	0.0363	CbGpPWpGaD
Nelarabine—ADA—Purine metabolism—PPAT—kidney cancer	0.000904	0.0258	CbGpPWpGaD
Nelarabine—DGUOK—renal system—kidney cancer	0.000877	0.205	CbGeAlD
Nelarabine—ADA—Purine metabolism—APRT—kidney cancer	0.00084	0.024	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—PPAT—kidney cancer	0.000834	0.0238	CbGpPWpGaD
Nelarabine—DGUOK—cortex of kidney—kidney cancer	0.000826	0.193	CbGeAlD
Nelarabine—DGUOK—cardiac atrium—kidney cancer	0.000786	0.184	CbGeAlD
Nelarabine—DCK—Purine metabolism—APRT—kidney cancer	0.000776	0.0221	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—FOSL2—kidney cancer	0.000745	0.0213	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.000731	0.0209	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—APAF1—kidney cancer	0.000605	0.468	CrCbGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.000535	0.0153	CbGpPWpGaD
Nelarabine—ADA—renal system—kidney cancer	0.000502	0.118	CbGeAlD
Nelarabine—ADA—Nucleotide metabolism—PPAT—kidney cancer	0.000454	0.013	CbGpPWpGaD
Nelarabine—Adenosine monophosphate—APRT—kidney cancer	0.00045	0.348	CrCbGaD
Nelarabine—ADA—Nucleotide metabolism—APRT—kidney cancer	0.000422	0.0121	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—PPAT—kidney cancer	0.000419	0.012	CbGpPWpGaD
Nelarabine—POLA1—Vinblastine—Vincristine—kidney cancer	0.000398	0.324	CbGdCrCtD
Nelarabine—DCK—Nucleotide metabolism—APRT—kidney cancer	0.00039	0.0111	CbGpPWpGaD
Nelarabine—DCK—nephron tubule—kidney cancer	0.000367	0.086	CbGeAlD
Nelarabine—DCK—Sirolimus—Everolimus—kidney cancer	0.000358	0.291	CbGdCrCtD
Nelarabine—DCK—Sirolimus—Temsirolimus—kidney cancer	0.000358	0.291	CbGdCrCtD
Nelarabine—ADA—p73 transcription factor network—IL4R—kidney cancer	0.000341	0.00972	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—TFE3—kidney cancer	0.000337	0.00963	CbGpPWpGaD
Nelarabine—DCK—cortex of kidney—kidney cancer	0.000314	0.0736	CbGeAlD
Nelarabine—DCK—gonad—kidney cancer	0.000299	0.0701	CbGeAlD
Nelarabine—DCK—cardiac atrium—kidney cancer	0.000299	0.07	CbGeAlD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—OGG1—kidney cancer	0.000292	0.00833	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—CASP2—kidney cancer	0.000269	0.00769	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CD34—kidney cancer	0.000246	0.00702	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—WT1—kidney cancer	0.00024	0.00685	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—kidney cancer	0.000214	0.00612	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—ALK—kidney cancer	0.000211	0.163	CrCbGaD
Nelarabine—POLA1—E2F transcription factor network—APAF1—kidney cancer	0.000182	0.0052	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ACY1—kidney cancer	0.000179	0.00512	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PDHB—kidney cancer	0.000152	0.00435	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CCBL1—kidney cancer	0.000143	0.00409	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—BRCA2—kidney cancer	0.000142	0.00404	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—HNF1B—kidney cancer	0.000137	0.00392	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—KCNMA1—kidney cancer	0.000134	0.00382	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication Pre-Initiation—PSMD7—kidney cancer	0.000127	0.00363	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—GSTM1—kidney cancer	0.000127	0.00361	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPAT—kidney cancer	0.000124	0.00355	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GLIPR1—kidney cancer	0.000124	0.00355	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—kidney cancer	0.000122	0.00347	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—JUND—kidney cancer	0.00012	0.00342	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—FH—kidney cancer	0.000116	0.0033	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APRT—kidney cancer	0.000116	0.0033	CbGpPWpGaD
Nelarabine—DCK—Epirubicin—Doxorubicin—kidney cancer	0.000115	0.0937	CbGdCrCtD
Nelarabine—POLA1—Synthesis of DNA—PSMD7—kidney cancer	0.000111	0.00317	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—kidney cancer	0.000109	0.0031	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GPC3—kidney cancer	0.000109	0.0031	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CA2—kidney cancer	0.000106	0.00302	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—PSMD7—kidney cancer	0.000104	0.00297	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALAD—kidney cancer	0.000103	0.00294	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ST3GAL2—kidney cancer	0.000101	0.00287	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—PSMD7—kidney cancer	0.0001	0.00286	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALDH1A1—kidney cancer	9.83e-05	0.0028	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC5A3—kidney cancer	9.42e-05	0.00269	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PGK1—kidney cancer	9.42e-05	0.00269	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—KIT—kidney cancer	9.41e-05	0.00268	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—SYNE2—kidney cancer	9.36e-05	0.00267	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LDHB—kidney cancer	9.24e-05	0.00264	CbGpPWpGaD
Nelarabine—POLA1—S Phase—PSMD7—kidney cancer	9.1e-05	0.0026	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—PSMD7—kidney cancer	8.45e-05	0.00241	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	8.44e-05	0.00241	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	8.44e-05	0.00241	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CA9—kidney cancer	8.01e-05	0.00229	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	8e-05	0.00228	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—RELA—kidney cancer	7.72e-05	0.0022	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CDKN2A—kidney cancer	7.64e-05	0.00218	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—EGR1—kidney cancer	7.64e-05	0.00218	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CD4—kidney cancer	7.19e-05	0.00205	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—PTGS2—kidney cancer	7.14e-05	0.00204	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	6.96e-05	0.00199	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CRABP1—kidney cancer	6.81e-05	0.00194	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CDKN1B—kidney cancer	6.76e-05	0.00193	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	6.62e-05	0.00189	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CCND1—kidney cancer	6.45e-05	0.00184	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	6.4e-05	0.00183	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ITPR2—kidney cancer	6.33e-05	0.00181	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	6.17e-05	0.00176	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	6.07e-05	0.00173	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ACY1—kidney cancer	5.95e-05	0.0017	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	5.79e-05	0.00165	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTT1—kidney cancer	5.77e-05	0.00165	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ACHE—kidney cancer	5.77e-05	0.00165	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN2A—kidney cancer	5.77e-05	0.00165	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	5.74e-05	0.00164	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	5.74e-05	0.00164	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ACY1—kidney cancer	5.49e-05	0.00157	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SCARB1—kidney cancer	5.47e-05	0.00156	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—MYC—kidney cancer	5.44e-05	0.00155	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS1—kidney cancer	5.41e-05	0.00154	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	5.37e-05	0.00153	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PSMD7—kidney cancer	5.31e-05	0.00151	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—MYC—kidney cancer	5.18e-05	0.00148	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN1B—kidney cancer	5.11e-05	0.00146	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PDHB—kidney cancer	5.06e-05	0.00144	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—BCHE—kidney cancer	5.03e-05	0.00144	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC5A5—kidney cancer	4.97e-05	0.00142	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	4.85e-05	0.00138	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC2A1—kidney cancer	4.8e-05	0.00137	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—KRAS—kidney cancer	4.78e-05	0.00136	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CCBL1—kidney cancer	4.76e-05	0.00136	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	4.72e-05	0.00135	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	4.68e-05	0.00133	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PDHB—kidney cancer	4.67e-05	0.00133	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	4.64e-05	0.00133	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	4.57e-05	0.0013	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	4.44e-05	0.00127	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CCBL1—kidney cancer	4.39e-05	0.00125	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	4.24e-05	0.00121	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PSMD7—kidney cancer	4.14e-05	0.00118	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPAT—kidney cancer	4.13e-05	0.00118	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GLIPR1—kidney cancer	4.13e-05	0.00118	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—CDKN1B—kidney cancer	4.11e-05	0.00117	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTP1—kidney cancer	4e-05	0.00114	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—MYC—kidney cancer	3.91e-05	0.00112	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CDKN1B—kidney cancer	3.85e-05	0.0011	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APRT—kidney cancer	3.84e-05	0.00109	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FH—kidney cancer	3.84e-05	0.00109	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	3.81e-05	0.00109	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPAT—kidney cancer	3.81e-05	0.00109	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GLIPR1—kidney cancer	3.81e-05	0.00109	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCB1—kidney cancer	3.79e-05	0.00108	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CDKN1B—kidney cancer	3.71e-05	0.00106	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTM1—kidney cancer	3.68e-05	0.00105	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPC3—kidney cancer	3.61e-05	0.00103	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APRT—kidney cancer	3.54e-05	0.00101	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FH—kidney cancer	3.54e-05	0.00101	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	3.53e-05	0.00101	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CA2—kidney cancer	3.51e-05	0.001	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP1A1—kidney cancer	3.49e-05	0.000995	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALAD—kidney cancer	3.42e-05	0.000976	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	3.4e-05	0.00097	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CDKN1B—kidney cancer	3.37e-05	0.000961	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ST3GAL2—kidney cancer	3.34e-05	0.000952	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPC3—kidney cancer	3.33e-05	0.00095	CbGpPWpGaD
Nelarabine—Asthenia—Erlotinib—kidney cancer	3.31e-05	0.000434	CcSEcCtD
Nelarabine—Mental disorder—Paclitaxel—kidney cancer	3.31e-05	0.000434	CcSEcCtD
Nelarabine—Thrombocytopenia—Vincristine—kidney cancer	3.3e-05	0.000434	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.29e-05	0.00094	CbGpPWpGaD
Nelarabine—Malnutrition—Paclitaxel—kidney cancer	3.28e-05	0.000431	CcSEcCtD
Nelarabine—Decreased appetite—Dactinomycin—kidney cancer	3.28e-05	0.000431	CcSEcCtD
Nelarabine—Diarrhoea—Vinblastine—kidney cancer	3.28e-05	0.000431	CcSEcCtD
Nelarabine—Body temperature increased—Sorafenib—kidney cancer	3.28e-05	0.00043	CcSEcCtD
Nelarabine—Abdominal pain—Sorafenib—kidney cancer	3.28e-05	0.00043	CcSEcCtD
Nelarabine—Diarrhoea—Everolimus—kidney cancer	3.27e-05	0.000429	CcSEcCtD
Nelarabine—Gastrointestinal pain—Sunitinib—kidney cancer	3.26e-05	0.000428	CcSEcCtD
Nelarabine—ADA—Metabolism—ALDH1A1—kidney cancer	3.26e-05	0.000931	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Capecitabine—kidney cancer	3.26e-05	0.000428	CcSEcCtD
Nelarabine—Fatigue—Dactinomycin—kidney cancer	3.26e-05	0.000428	CcSEcCtD
Nelarabine—Epistaxis—Capecitabine—kidney cancer	3.25e-05	0.000427	CcSEcCtD
Nelarabine—DCK—Metabolism—CA2—kidney cancer	3.24e-05	0.000924	CbGpPWpGaD
Nelarabine—Pain—Dactinomycin—kidney cancer	3.23e-05	0.000424	CcSEcCtD
Nelarabine—Anorexia—Vincristine—kidney cancer	3.22e-05	0.000422	CcSEcCtD
Nelarabine—Dysgeusia—Paclitaxel—kidney cancer	3.22e-05	0.000422	CcSEcCtD
Nelarabine—POLA1—S Phase—CCND1—kidney cancer	3.21e-05	0.000917	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—JUN—kidney cancer	3.2e-05	0.000914	CbGpPWpGaD
Nelarabine—Oedema—Gemcitabine—kidney cancer	3.2e-05	0.00042	CcSEcCtD
Nelarabine—Infection—Gemcitabine—kidney cancer	3.18e-05	0.000418	CcSEcCtD
Nelarabine—Back pain—Paclitaxel—kidney cancer	3.18e-05	0.000417	CcSEcCtD
Nelarabine—Dizziness—Vinblastine—kidney cancer	3.17e-05	0.000416	CcSEcCtD
Nelarabine—Dizziness—Everolimus—kidney cancer	3.16e-05	0.000415	CcSEcCtD
Nelarabine—DCK—Metabolism—ALAD—kidney cancer	3.16e-05	0.0009	CbGpPWpGaD
Nelarabine—Body temperature increased—Sunitinib—kidney cancer	3.15e-05	0.000414	CcSEcCtD
Nelarabine—Abdominal pain—Sunitinib—kidney cancer	3.15e-05	0.000414	CcSEcCtD
Nelarabine—Diarrhoea—Erlotinib—kidney cancer	3.15e-05	0.000414	CcSEcCtD
Nelarabine—Hypotension—Vincristine—kidney cancer	3.15e-05	0.000414	CcSEcCtD
Nelarabine—Nervous system disorder—Gemcitabine—kidney cancer	3.14e-05	0.000412	CcSEcCtD
Nelarabine—Thrombocytopenia—Gemcitabine—kidney cancer	3.13e-05	0.000412	CcSEcCtD
Nelarabine—ADA—Metabolism—PGK1—kidney cancer	3.13e-05	0.000892	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC5A3—kidney cancer	3.13e-05	0.000892	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	3.13e-05	0.000892	CbGpPWpGaD
Nelarabine—Feeling abnormal—Dactinomycin—kidney cancer	3.11e-05	0.000409	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—PTEN—kidney cancer	3.1e-05	0.000884	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PSMD7—kidney cancer	3.1e-05	0.000884	CbGpPWpGaD
Nelarabine—Vision blurred—Paclitaxel—kidney cancer	3.1e-05	0.000406	CcSEcCtD
Nelarabine—Gastrointestinal pain—Dactinomycin—kidney cancer	3.09e-05	0.000406	CcSEcCtD
Nelarabine—Hypoaesthesia—Capecitabine—kidney cancer	3.08e-05	0.000405	CcSEcCtD
Nelarabine—DCK—Metabolism—ST3GAL2—kidney cancer	3.08e-05	0.000879	CbGpPWpGaD
Nelarabine—Tremor—Paclitaxel—kidney cancer	3.08e-05	0.000404	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Vincristine—kidney cancer	3.07e-05	0.000404	CcSEcCtD
Nelarabine—ADA—Metabolism—LDHB—kidney cancer	3.07e-05	0.000875	CbGpPWpGaD
Nelarabine—Urinary tract disorder—Capecitabine—kidney cancer	3.06e-05	0.000402	CcSEcCtD
Nelarabine—Insomnia—Vincristine—kidney cancer	3.05e-05	0.000401	CcSEcCtD
Nelarabine—Anorexia—Gemcitabine—kidney cancer	3.05e-05	0.000401	CcSEcCtD
Nelarabine—Oedema peripheral—Capecitabine—kidney cancer	3.05e-05	0.000401	CcSEcCtD
Nelarabine—Vomiting—Vinblastine—kidney cancer	3.05e-05	0.0004	CcSEcCtD
Nelarabine—Dizziness—Erlotinib—kidney cancer	3.05e-05	0.0004	CcSEcCtD
Nelarabine—Connective tissue disorder—Capecitabine—kidney cancer	3.04e-05	0.0004	CcSEcCtD
Nelarabine—Vomiting—Everolimus—kidney cancer	3.04e-05	0.000399	CcSEcCtD
Nelarabine—Anaemia—Paclitaxel—kidney cancer	3.04e-05	0.000399	CcSEcCtD
Nelarabine—Urethral disorder—Capecitabine—kidney cancer	3.04e-05	0.000399	CcSEcCtD
Nelarabine—Paraesthesia—Vincristine—kidney cancer	3.03e-05	0.000398	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—AURKA—kidney cancer	3.01e-05	0.00086	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALDH1A1—kidney cancer	3.01e-05	0.000859	CbGpPWpGaD
Nelarabine—Headache—Vinblastine—kidney cancer	3e-05	0.000395	CcSEcCtD
Nelarabine—Headache—Everolimus—kidney cancer	2.99e-05	0.000393	CcSEcCtD
Nelarabine—Hypotension—Gemcitabine—kidney cancer	2.99e-05	0.000393	CcSEcCtD
Nelarabine—Body temperature increased—Dactinomycin—kidney cancer	2.99e-05	0.000392	CcSEcCtD
Nelarabine—Abdominal pain—Dactinomycin—kidney cancer	2.99e-05	0.000392	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCND1—kidney cancer	2.98e-05	0.000851	CbGpPWpGaD
Nelarabine—Asthenia—Sorafenib—kidney cancer	2.98e-05	0.000391	CcSEcCtD
Nelarabine—Hypoglycaemia—Doxorubicin—kidney cancer	2.96e-05	0.000388	CcSEcCtD
Nelarabine—Lethargy—Doxorubicin—kidney cancer	2.94e-05	0.000387	CcSEcCtD
Nelarabine—Leukopenia—Paclitaxel—kidney cancer	2.94e-05	0.000386	CcSEcCtD
Nelarabine—Decreased appetite—Vincristine—kidney cancer	2.93e-05	0.000385	CcSEcCtD
Nelarabine—Vomiting—Erlotinib—kidney cancer	2.93e-05	0.000385	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	2.92e-05	0.000383	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Vincristine—kidney cancer	2.91e-05	0.000383	CcSEcCtD
Nelarabine—Fatigue—Vincristine—kidney cancer	2.91e-05	0.000382	CcSEcCtD
Nelarabine—Insomnia—Gemcitabine—kidney cancer	2.9e-05	0.00038	CcSEcCtD
Nelarabine—Eye disorder—Capecitabine—kidney cancer	2.89e-05	0.00038	CcSEcCtD
Nelarabine—Headache—Erlotinib—kidney cancer	2.89e-05	0.000379	CcSEcCtD
Nelarabine—Loss of consciousness—Paclitaxel—kidney cancer	2.89e-05	0.000379	CcSEcCtD
Nelarabine—DCK—Metabolism—SLC5A3—kidney cancer	2.89e-05	0.000824	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PGK1—kidney cancer	2.89e-05	0.000824	CbGpPWpGaD
Nelarabine—Constipation—Vincristine—kidney cancer	2.89e-05	0.000379	CcSEcCtD
Nelarabine—Pain—Vincristine—kidney cancer	2.89e-05	0.000379	CcSEcCtD
Nelarabine—Pain in extremity—Doxorubicin—kidney cancer	2.89e-05	0.000379	CcSEcCtD
Nelarabine—Osteoarthritis—Doxorubicin—kidney cancer	2.89e-05	0.000379	CcSEcCtD
Nelarabine—Paraesthesia—Gemcitabine—kidney cancer	2.87e-05	0.000378	CcSEcCtD
Nelarabine—Cardiac disorder—Capecitabine—kidney cancer	2.87e-05	0.000377	CcSEcCtD
Nelarabine—Adenosine triphosphate—ABCB1—kidney cancer	2.87e-05	0.0222	CrCbGaD
Nelarabine—Cough—Paclitaxel—kidney cancer	2.87e-05	0.000376	CcSEcCtD
Nelarabine—Asthenia—Sunitinib—kidney cancer	2.86e-05	0.000376	CcSEcCtD
Nelarabine—Dyspnoea—Gemcitabine—kidney cancer	2.85e-05	0.000375	CcSEcCtD
Nelarabine—Nausea—Vinblastine—kidney cancer	2.85e-05	0.000374	CcSEcCtD
Nelarabine—Somnolence—Gemcitabine—kidney cancer	2.85e-05	0.000374	CcSEcCtD
Nelarabine—Convulsion—Paclitaxel—kidney cancer	2.85e-05	0.000374	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—MYC—kidney cancer	2.84e-05	0.00081	CbGpPWpGaD
Nelarabine—Nausea—Everolimus—kidney cancer	2.84e-05	0.000373	CcSEcCtD
Nelarabine—Diarrhoea—Sorafenib—kidney cancer	2.84e-05	0.000373	CcSEcCtD
Nelarabine—DCK—Metabolism—LDHB—kidney cancer	2.83e-05	0.000808	CbGpPWpGaD
Nelarabine—Angiopathy—Capecitabine—kidney cancer	2.81e-05	0.000369	CcSEcCtD
Nelarabine—Myalgia—Paclitaxel—kidney cancer	2.8e-05	0.000367	CcSEcCtD
Nelarabine—Chest pain—Paclitaxel—kidney cancer	2.8e-05	0.000367	CcSEcCtD
Nelarabine—Arthralgia—Paclitaxel—kidney cancer	2.8e-05	0.000367	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	2.79e-05	0.000797	CbGpPWpGaD
Nelarabine—Mediastinal disorder—Capecitabine—kidney cancer	2.79e-05	0.000366	CcSEcCtD
Nelarabine—Decreased appetite—Gemcitabine—kidney cancer	2.78e-05	0.000365	CcSEcCtD
Nelarabine—Chills—Capecitabine—kidney cancer	2.78e-05	0.000365	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—PSMD7—kidney cancer	2.77e-05	0.00079	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.76e-05	0.000363	CcSEcCtD
Nelarabine—Fatigue—Gemcitabine—kidney cancer	2.76e-05	0.000362	CcSEcCtD
Nelarabine—Gastrointestinal pain—Vincristine—kidney cancer	2.76e-05	0.000362	CcSEcCtD
Nelarabine—Dizziness—Sorafenib—kidney cancer	2.74e-05	0.00036	CcSEcCtD
Nelarabine—Constipation—Gemcitabine—kidney cancer	2.74e-05	0.00036	CcSEcCtD
Nelarabine—Pain—Gemcitabine—kidney cancer	2.74e-05	0.00036	CcSEcCtD
Nelarabine—Nausea—Erlotinib—kidney cancer	2.74e-05	0.00036	CcSEcCtD
Nelarabine—Diarrhoea—Sunitinib—kidney cancer	2.73e-05	0.000359	CcSEcCtD
Nelarabine—Ataxia—Doxorubicin—kidney cancer	2.71e-05	0.000356	CcSEcCtD
Nelarabine—Mental disorder—Capecitabine—kidney cancer	2.71e-05	0.000356	CcSEcCtD
Nelarabine—Asthenia—Dactinomycin—kidney cancer	2.71e-05	0.000356	CcSEcCtD
Nelarabine—Confusional state—Paclitaxel—kidney cancer	2.7e-05	0.000355	CcSEcCtD
Nelarabine—Blood creatinine increased—Doxorubicin—kidney cancer	2.7e-05	0.000355	CcSEcCtD
Nelarabine—Malnutrition—Capecitabine—kidney cancer	2.7e-05	0.000354	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—AURKA—kidney cancer	2.69e-05	0.000769	CbGpPWpGaD
Nelarabine—Dehydration—Doxorubicin—kidney cancer	2.68e-05	0.000352	CcSEcCtD
Nelarabine—Oedema—Paclitaxel—kidney cancer	2.68e-05	0.000352	CcSEcCtD
Nelarabine—Abdominal pain—Vincristine—kidney cancer	2.67e-05	0.00035	CcSEcCtD
Nelarabine—Body temperature increased—Vincristine—kidney cancer	2.67e-05	0.00035	CcSEcCtD
Nelarabine—Infection—Paclitaxel—kidney cancer	2.66e-05	0.00035	CcSEcCtD
Nelarabine—ADA—Metabolism—CA9—kidney cancer	2.66e-05	0.000759	CbGpPWpGaD
Nelarabine—Dysgeusia—Capecitabine—kidney cancer	2.64e-05	0.000347	CcSEcCtD
Nelarabine—Dizziness—Sunitinib—kidney cancer	2.64e-05	0.000346	CcSEcCtD
Nelarabine—Feeling abnormal—Gemcitabine—kidney cancer	2.64e-05	0.000346	CcSEcCtD
Nelarabine—Vomiting—Sorafenib—kidney cancer	2.64e-05	0.000346	CcSEcCtD
Nelarabine—Nervous system disorder—Paclitaxel—kidney cancer	2.63e-05	0.000345	CcSEcCtD
Nelarabine—Hypokalaemia—Doxorubicin—kidney cancer	2.63e-05	0.000345	CcSEcCtD
Nelarabine—Thrombocytopenia—Paclitaxel—kidney cancer	2.62e-05	0.000345	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—kidney cancer	2.61e-05	0.000745	CbGpPWpGaD
Nelarabine—Back pain—Capecitabine—kidney cancer	2.61e-05	0.000342	CcSEcCtD
Nelarabine—DGUOK—Metabolism—POMC—kidney cancer	2.6e-05	0.000742	CbGpPWpGaD
Nelarabine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	2.6e-05	0.000341	CcSEcCtD
Nelarabine—Headache—Sorafenib—kidney cancer	2.6e-05	0.000341	CcSEcCtD
Nelarabine—Diarrhoea—Dactinomycin—kidney cancer	2.58e-05	0.000339	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.58e-05	0.000738	CbGpPWpGaD
Nelarabine—POLA1—S Phase—MYC—kidney cancer	2.58e-05	0.000735	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.56e-05	0.00073	CbGpPWpGaD
Nelarabine—Anorexia—Paclitaxel—kidney cancer	2.56e-05	0.000336	CcSEcCtD
Nelarabine—Muscular weakness—Doxorubicin—kidney cancer	2.54e-05	0.000334	CcSEcCtD
Nelarabine—Vision blurred—Capecitabine—kidney cancer	2.54e-05	0.000334	CcSEcCtD
Nelarabine—Vomiting—Sunitinib—kidney cancer	2.54e-05	0.000333	CcSEcCtD
Nelarabine—Body temperature increased—Gemcitabine—kidney cancer	2.53e-05	0.000332	CcSEcCtD
Nelarabine—Tremor—Capecitabine—kidney cancer	2.53e-05	0.000332	CcSEcCtD
Nelarabine—Abdominal distension—Doxorubicin—kidney cancer	2.51e-05	0.00033	CcSEcCtD
Nelarabine—Hypotension—Paclitaxel—kidney cancer	2.5e-05	0.000329	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.5e-05	0.000713	CbGpPWpGaD
Nelarabine—Headache—Sunitinib—kidney cancer	2.5e-05	0.000328	CcSEcCtD
Nelarabine—Anaemia—Capecitabine—kidney cancer	2.49e-05	0.000327	CcSEcCtD
Nelarabine—Nausea—Sorafenib—kidney cancer	2.46e-05	0.000323	CcSEcCtD
Nelarabine—DCK—Metabolism—CA9—kidney cancer	2.45e-05	0.0007	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.44e-05	0.000321	CcSEcCtD
Nelarabine—Insomnia—Paclitaxel—kidney cancer	2.42e-05	0.000318	CcSEcCtD
Nelarabine—Asthenia—Vincristine—kidney cancer	2.42e-05	0.000318	CcSEcCtD
Nelarabine—Leukopenia—Capecitabine—kidney cancer	2.41e-05	0.000317	CcSEcCtD
Nelarabine—Paraesthesia—Paclitaxel—kidney cancer	2.41e-05	0.000316	CcSEcCtD
Nelarabine—Vomiting—Dactinomycin—kidney cancer	2.4e-05	0.000315	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—kidney cancer	2.39e-05	0.000683	CbGpPWpGaD
Nelarabine—Dyspnoea—Paclitaxel—kidney cancer	2.39e-05	0.000314	CcSEcCtD
Nelarabine—Somnolence—Paclitaxel—kidney cancer	2.38e-05	0.000313	CcSEcCtD
Nelarabine—Nausea—Sunitinib—kidney cancer	2.37e-05	0.000311	CcSEcCtD
Nelarabine—Loss of consciousness—Capecitabine—kidney cancer	2.37e-05	0.000311	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.37e-05	0.000676	CbGpPWpGaD
Nelarabine—Cough—Capecitabine—kidney cancer	2.35e-05	0.000309	CcSEcCtD
Nelarabine—Neutropenia—Doxorubicin—kidney cancer	2.33e-05	0.000306	CcSEcCtD
Nelarabine—Decreased appetite—Paclitaxel—kidney cancer	2.33e-05	0.000306	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.31e-05	0.000304	CcSEcCtD
Nelarabine—Fatigue—Paclitaxel—kidney cancer	2.31e-05	0.000303	CcSEcCtD
Nelarabine—Diarrhoea—Vincristine—kidney cancer	2.31e-05	0.000303	CcSEcCtD
Nelarabine—Asthenia—Gemcitabine—kidney cancer	2.3e-05	0.000302	CcSEcCtD
Nelarabine—Myalgia—Capecitabine—kidney cancer	2.29e-05	0.000301	CcSEcCtD
Nelarabine—Arthralgia—Capecitabine—kidney cancer	2.29e-05	0.000301	CcSEcCtD
Nelarabine—Chest pain—Capecitabine—kidney cancer	2.29e-05	0.000301	CcSEcCtD
Nelarabine—Pain—Paclitaxel—kidney cancer	2.29e-05	0.000301	CcSEcCtD
Nelarabine—Constipation—Paclitaxel—kidney cancer	2.29e-05	0.000301	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—kidney cancer	2.26e-05	0.000646	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CRABP1—kidney cancer	2.26e-05	0.000645	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.26e-05	0.000645	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.25e-05	0.000643	CbGpPWpGaD
Nelarabine—Hyperglycaemia—Doxorubicin—kidney cancer	2.25e-05	0.000295	CcSEcCtD
Nelarabine—Nausea—Dactinomycin—kidney cancer	2.24e-05	0.000295	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.24e-05	0.000638	CbGpPWpGaD
Nelarabine—Pneumonia—Doxorubicin—kidney cancer	2.24e-05	0.000294	CcSEcCtD
Nelarabine—Dizziness—Vincristine—kidney cancer	2.23e-05	0.000293	CcSEcCtD
Nelarabine—Infestation NOS—Doxorubicin—kidney cancer	2.22e-05	0.000292	CcSEcCtD
Nelarabine—Infestation—Doxorubicin—kidney cancer	2.22e-05	0.000292	CcSEcCtD
Nelarabine—Confusional state—Capecitabine—kidney cancer	2.22e-05	0.000291	CcSEcCtD
Nelarabine—Feeling abnormal—Paclitaxel—kidney cancer	2.21e-05	0.00029	CcSEcCtD
Nelarabine—Oedema—Capecitabine—kidney cancer	2.2e-05	0.000289	CcSEcCtD
Nelarabine—Gastrointestinal pain—Paclitaxel—kidney cancer	2.19e-05	0.000288	CcSEcCtD
Nelarabine—Diarrhoea—Gemcitabine—kidney cancer	2.19e-05	0.000288	CcSEcCtD
Nelarabine—Infection—Capecitabine—kidney cancer	2.19e-05	0.000287	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.18e-05	0.000622	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Doxorubicin—kidney cancer	2.18e-05	0.000286	CcSEcCtD
Nelarabine—Stomatitis—Doxorubicin—kidney cancer	2.17e-05	0.000285	CcSEcCtD
Nelarabine—Nervous system disorder—Capecitabine—kidney cancer	2.16e-05	0.000283	CcSEcCtD
Nelarabine—Thrombocytopenia—Capecitabine—kidney cancer	2.15e-05	0.000283	CcSEcCtD
Nelarabine—Vomiting—Vincristine—kidney cancer	2.15e-05	0.000282	CcSEcCtD
Nelarabine—Abdominal pain—Paclitaxel—kidney cancer	2.12e-05	0.000278	CcSEcCtD
Nelarabine—Body temperature increased—Paclitaxel—kidney cancer	2.12e-05	0.000278	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—TP53—kidney cancer	2.11e-05	0.000604	CbGpPWpGaD
Nelarabine—Headache—Vincristine—kidney cancer	2.11e-05	0.000278	CcSEcCtD
Nelarabine—Hepatobiliary disease—Doxorubicin—kidney cancer	2.1e-05	0.000276	CcSEcCtD
Nelarabine—ADA—Metabolism—ITPR2—kidney cancer	2.1e-05	0.0006	CbGpPWpGaD
Nelarabine—Epistaxis—Doxorubicin—kidney cancer	2.1e-05	0.000275	CcSEcCtD
Nelarabine—Anorexia—Capecitabine—kidney cancer	2.1e-05	0.000275	CcSEcCtD
Nelarabine—DCK—Metabolism—CRABP1—kidney cancer	2.09e-05	0.000595	CbGpPWpGaD
Nelarabine—Sinusitis—Doxorubicin—kidney cancer	2.09e-05	0.000274	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTGS2—kidney cancer	2.07e-05	0.000592	CbGpPWpGaD
Nelarabine—Hypotension—Capecitabine—kidney cancer	2.06e-05	0.00027	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—BRCA2—kidney cancer	2.04e-05	0.000583	CbGpPWpGaD
Nelarabine—Vomiting—Gemcitabine—kidney cancer	2.04e-05	0.000267	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CDKN2B—kidney cancer	2.02e-05	0.000578	CbGpPWpGaD
Nelarabine—Headache—Gemcitabine—kidney cancer	2.01e-05	0.000263	CcSEcCtD
Nelarabine—Nausea—Vincristine—kidney cancer	2e-05	0.000263	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Capecitabine—kidney cancer	2e-05	0.000263	CcSEcCtD
Nelarabine—Insomnia—Capecitabine—kidney cancer	1.99e-05	0.000261	CcSEcCtD
Nelarabine—Hypoaesthesia—Doxorubicin—kidney cancer	1.99e-05	0.000261	CcSEcCtD
Nelarabine—Paraesthesia—Capecitabine—kidney cancer	1.98e-05	0.000259	CcSEcCtD
Nelarabine—Urinary tract disorder—Doxorubicin—kidney cancer	1.97e-05	0.000259	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.97e-05	0.000562	CbGpPWpGaD
Nelarabine—Oedema peripheral—Doxorubicin—kidney cancer	1.97e-05	0.000258	CcSEcCtD
Nelarabine—Connective tissue disorder—Doxorubicin—kidney cancer	1.96e-05	0.000258	CcSEcCtD
Nelarabine—Dyspnoea—Capecitabine—kidney cancer	1.96e-05	0.000258	CcSEcCtD
Nelarabine—Urethral disorder—Doxorubicin—kidney cancer	1.96e-05	0.000257	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—BIRC5—kidney cancer	1.95e-05	0.000557	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ITPR2—kidney cancer	1.94e-05	0.000554	CbGpPWpGaD
Nelarabine—Asthenia—Paclitaxel—kidney cancer	1.92e-05	0.000253	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTT1—kidney cancer	1.92e-05	0.000547	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ACHE—kidney cancer	1.92e-05	0.000547	CbGpPWpGaD
Nelarabine—Decreased appetite—Capecitabine—kidney cancer	1.91e-05	0.000251	CcSEcCtD
Nelarabine—Nausea—Gemcitabine—kidney cancer	1.9e-05	0.00025	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Capecitabine—kidney cancer	1.9e-05	0.000249	CcSEcCtD
Nelarabine—Fatigue—Capecitabine—kidney cancer	1.9e-05	0.000249	CcSEcCtD
Nelarabine—Constipation—Capecitabine—kidney cancer	1.88e-05	0.000247	CcSEcCtD
Nelarabine—Pain—Capecitabine—kidney cancer	1.88e-05	0.000247	CcSEcCtD
Nelarabine—Eye disorder—Doxorubicin—kidney cancer	1.87e-05	0.000245	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.86e-05	0.000532	CbGpPWpGaD
Nelarabine—Cardiac disorder—Doxorubicin—kidney cancer	1.85e-05	0.000243	CcSEcCtD
Nelarabine—Diarrhoea—Paclitaxel—kidney cancer	1.83e-05	0.000241	CcSEcCtD
Nelarabine—ADA—Metabolism—SCARB1—kidney cancer	1.81e-05	0.000518	CbGpPWpGaD
Nelarabine—Feeling abnormal—Capecitabine—kidney cancer	1.81e-05	0.000238	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.81e-05	0.000517	CbGpPWpGaD
Nelarabine—Angiopathy—Doxorubicin—kidney cancer	1.81e-05	0.000238	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTEN—kidney cancer	1.81e-05	0.000516	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Capecitabine—kidney cancer	1.8e-05	0.000236	CcSEcCtD
Nelarabine—Mediastinal disorder—Doxorubicin—kidney cancer	1.8e-05	0.000236	CcSEcCtD
Nelarabine—ADA—Metabolism—PTGS1—kidney cancer	1.8e-05	0.000513	CbGpPWpGaD
Nelarabine—Chills—Doxorubicin—kidney cancer	1.79e-05	0.000235	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.77e-05	0.000506	CbGpPWpGaD
Nelarabine—Dizziness—Paclitaxel—kidney cancer	1.77e-05	0.000233	CcSEcCtD
Nelarabine—DCK—Metabolism—ACHE—kidney cancer	1.77e-05	0.000505	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTT1—kidney cancer	1.77e-05	0.000505	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PSMD7—kidney cancer	1.76e-05	0.000503	CbGpPWpGaD
Nelarabine—Mental disorder—Doxorubicin—kidney cancer	1.75e-05	0.00023	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—BIRC5—kidney cancer	1.75e-05	0.000498	CbGpPWpGaD
Nelarabine—Abdominal pain—Capecitabine—kidney cancer	1.74e-05	0.000228	CcSEcCtD
Nelarabine—Body temperature increased—Capecitabine—kidney cancer	1.74e-05	0.000228	CcSEcCtD
Nelarabine—Malnutrition—Doxorubicin—kidney cancer	1.74e-05	0.000228	CcSEcCtD
Nelarabine—Vomiting—Paclitaxel—kidney cancer	1.7e-05	0.000224	CcSEcCtD
Nelarabine—Dysgeusia—Doxorubicin—kidney cancer	1.7e-05	0.000223	CcSEcCtD
Nelarabine—Back pain—Doxorubicin—kidney cancer	1.68e-05	0.000221	CcSEcCtD
Nelarabine—Headache—Paclitaxel—kidney cancer	1.68e-05	0.000221	CcSEcCtD
Nelarabine—DCK—Metabolism—SCARB1—kidney cancer	1.67e-05	0.000478	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.67e-05	0.000478	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BCHE—kidney cancer	1.67e-05	0.000477	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS1—kidney cancer	1.66e-05	0.000473	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC5A5—kidney cancer	1.65e-05	0.000471	CbGpPWpGaD
Nelarabine—Vision blurred—Doxorubicin—kidney cancer	1.64e-05	0.000215	CcSEcCtD
Nelarabine—DCK—Metabolism—PSMD7—kidney cancer	1.63e-05	0.000464	CbGpPWpGaD
Nelarabine—Anaemia—Doxorubicin—kidney cancer	1.61e-05	0.000211	CcSEcCtD
Nelarabine—ADA—Metabolism—SLC2A1—kidney cancer	1.59e-05	0.000455	CbGpPWpGaD
Nelarabine—Nausea—Paclitaxel—kidney cancer	1.59e-05	0.000209	CcSEcCtD
Nelarabine—Asthenia—Capecitabine—kidney cancer	1.58e-05	0.000207	CcSEcCtD
Nelarabine—Leukopenia—Doxorubicin—kidney cancer	1.56e-05	0.000204	CcSEcCtD
Nelarabine—DCK—Metabolism—BCHE—kidney cancer	1.54e-05	0.00044	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.54e-05	0.000439	CbGpPWpGaD
Nelarabine—Loss of consciousness—Doxorubicin—kidney cancer	1.53e-05	0.000201	CcSEcCtD
Nelarabine—DCK—Metabolism—SLC5A5—kidney cancer	1.52e-05	0.000434	CbGpPWpGaD
Nelarabine—Cough—Doxorubicin—kidney cancer	1.52e-05	0.000199	CcSEcCtD
Nelarabine—Convulsion—Doxorubicin—kidney cancer	1.51e-05	0.000198	CcSEcCtD
Nelarabine—Diarrhoea—Capecitabine—kidney cancer	1.51e-05	0.000198	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.49e-05	0.000425	CbGpPWpGaD
Nelarabine—Chest pain—Doxorubicin—kidney cancer	1.48e-05	0.000194	CcSEcCtD
Nelarabine—Myalgia—Doxorubicin—kidney cancer	1.48e-05	0.000194	CcSEcCtD
Nelarabine—Arthralgia—Doxorubicin—kidney cancer	1.48e-05	0.000194	CcSEcCtD
Nelarabine—DCK—Metabolism—SLC2A1—kidney cancer	1.47e-05	0.00042	CbGpPWpGaD
Nelarabine—Dizziness—Capecitabine—kidney cancer	1.45e-05	0.000191	CcSEcCtD
Nelarabine—Confusional state—Doxorubicin—kidney cancer	1.43e-05	0.000188	CcSEcCtD
Nelarabine—Oedema—Doxorubicin—kidney cancer	1.42e-05	0.000186	CcSEcCtD
Nelarabine—Infection—Doxorubicin—kidney cancer	1.41e-05	0.000185	CcSEcCtD
Nelarabine—Vomiting—Capecitabine—kidney cancer	1.4e-05	0.000184	CcSEcCtD
Nelarabine—Nervous system disorder—Doxorubicin—kidney cancer	1.39e-05	0.000183	CcSEcCtD
Nelarabine—Thrombocytopenia—Doxorubicin—kidney cancer	1.39e-05	0.000182	CcSEcCtD
Nelarabine—Headache—Capecitabine—kidney cancer	1.38e-05	0.000181	CcSEcCtD
Nelarabine—Anorexia—Doxorubicin—kidney cancer	1.35e-05	0.000177	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTP1—kidney cancer	1.33e-05	0.000379	CbGpPWpGaD
Nelarabine—Hypotension—Doxorubicin—kidney cancer	1.33e-05	0.000174	CcSEcCtD
Nelarabine—Nausea—Capecitabine—kidney cancer	1.31e-05	0.000172	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—kidney cancer	1.29e-05	0.000369	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.29e-05	0.00017	CcSEcCtD
Nelarabine—Insomnia—Doxorubicin—kidney cancer	1.28e-05	0.000168	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CA—kidney cancer	1.28e-05	0.000364	CbGpPWpGaD
Nelarabine—Paraesthesia—Doxorubicin—kidney cancer	1.27e-05	0.000167	CcSEcCtD
Nelarabine—Dyspnoea—Doxorubicin—kidney cancer	1.26e-05	0.000166	CcSEcCtD
Nelarabine—Somnolence—Doxorubicin—kidney cancer	1.26e-05	0.000166	CcSEcCtD
Nelarabine—ADA—Metabolism—ABCB1—kidney cancer	1.26e-05	0.000359	CbGpPWpGaD
Nelarabine—Decreased appetite—Doxorubicin—kidney cancer	1.23e-05	0.000162	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTP1—kidney cancer	1.23e-05	0.00035	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.22e-05	0.000161	CcSEcCtD
Nelarabine—Fatigue—Doxorubicin—kidney cancer	1.22e-05	0.000161	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTM1—kidney cancer	1.22e-05	0.000348	CbGpPWpGaD
Nelarabine—Constipation—Doxorubicin—kidney cancer	1.21e-05	0.000159	CcSEcCtD
Nelarabine—Pain—Doxorubicin—kidney cancer	1.21e-05	0.000159	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—kidney cancer	1.21e-05	0.000344	CbGpPWpGaD
Nelarabine—Feeling abnormal—Doxorubicin—kidney cancer	1.17e-05	0.000153	CcSEcCtD
Nelarabine—DCK—Metabolism—ABCB1—kidney cancer	1.16e-05	0.000331	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Doxorubicin—kidney cancer	1.16e-05	0.000152	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP1A1—kidney cancer	1.16e-05	0.00033	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2A—kidney cancer	1.16e-05	0.00033	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—kidney cancer	1.15e-05	0.000327	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.15e-05	0.000327	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTM1—kidney cancer	1.13e-05	0.000322	CbGpPWpGaD
Nelarabine—Body temperature increased—Doxorubicin—kidney cancer	1.12e-05	0.000147	CcSEcCtD
Nelarabine—Abdominal pain—Doxorubicin—kidney cancer	1.12e-05	0.000147	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND1—kidney cancer	1.09e-05	0.000312	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP1A1—kidney cancer	1.07e-05	0.000305	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1B—kidney cancer	1.03e-05	0.000293	CbGpPWpGaD
Nelarabine—Asthenia—Doxorubicin—kidney cancer	1.02e-05	0.000134	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CCND1—kidney cancer	9.78e-06	0.000279	CbGpPWpGaD
Nelarabine—Diarrhoea—Doxorubicin—kidney cancer	9.7e-06	0.000127	CcSEcCtD
Nelarabine—Dizziness—Doxorubicin—kidney cancer	9.38e-06	0.000123	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK3—kidney cancer	9.02e-06	0.000257	CbGpPWpGaD
Nelarabine—Vomiting—Doxorubicin—kidney cancer	9.02e-06	0.000118	CcSEcCtD
Nelarabine—Headache—Doxorubicin—kidney cancer	8.88e-06	0.000117	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—kidney cancer	8.77e-06	0.00025	CbGpPWpGaD
Nelarabine—ADA—Metabolism—POMC—kidney cancer	8.63e-06	0.000246	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK1—kidney cancer	8.58e-06	0.000245	CbGpPWpGaD
Nelarabine—Nausea—Doxorubicin—kidney cancer	8.42e-06	0.000111	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—MAPK3—kidney cancer	8.06e-06	0.00023	CbGpPWpGaD
Nelarabine—DCK—Metabolism—POMC—kidney cancer	7.96e-06	0.000227	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—kidney cancer	7.84e-06	0.000224	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK1—kidney cancer	7.67e-06	0.000219	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—kidney cancer	6.88e-06	0.000196	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—kidney cancer	6.44e-06	0.000184	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—kidney cancer	6.35e-06	0.000181	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTEN—kidney cancer	6e-06	0.000171	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTEN—kidney cancer	5.54e-06	0.000158	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—kidney cancer	4.24e-06	0.000121	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—kidney cancer	3.91e-06	0.000112	CbGpPWpGaD
